Efficacy and Safety of Short Course Radiotherapy Combined With CAPOX and PD-1/CTLA-4 Bispecific Antibody QL1706 in Patients With Liver Metastases From Rectal Cancer
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs Iparomlimab/tuvonralimab (Primary) ; Capecitabine; Oxaliplatin
- Indications Liver metastases; Rectal cancer
- Focus Therapeutic Use
- Acronyms SCARLET
- 29 Jan 2025 New trial record